BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 36583477)

  • 1. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
    Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
    J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
    Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
    J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
    Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
    Front Public Health; 2022; 10():900294. PubMed ID: 35958856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Treatment Parameters on Racial Survival Differences in Oropharyngeal Cancer: National Cancer Database Study.
    Zhu D; Wong A; Oh EJ; Ahn S; Wotman M; Sahai T; Bottalico D; Frank D; Tham T
    Otolaryngol Head Neck Surg; 2022 Jun; 166(6):1134-1143. PubMed ID: 34399637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinoma.
    Yan EZ; Wahle BM; Massa ST; Zolkind P; Paniello RC; Pipkorn P; Jackson RS; Rich JT; Puram SV; Mazul AL
    Cancer Med; 2023 Apr; 12(8):9976-9987. PubMed ID: 36847063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
    Bauer E; Mazul A; Chernock R; Rich J; Jackson RS; Paniello R; Pipkorn P; Oppelt P; Gay H; Daly M; El-Mofty S; Thorstad W; Adkins D; Zevallos J
    Laryngoscope; 2020 Apr; 130(4):939-945. PubMed ID: 31077394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.
    Settle K; Posner MR; Schumaker LM; Tan M; Suntharalingam M; Goloubeva O; Strome SE; Haddad RI; Patel SS; Cambell EV; Sarlis N; Lorch J; Cullen KJ
    Cancer Prev Res (Phila); 2009 Sep; 2(9):776-81. PubMed ID: 19641042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
    Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
    Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Koyuncu CF; Nag R; Lu C; Corredor G; Viswanathan VS; Sandulache VC; Fu P; Yang K; Pan Q; Zhang Z; Xu J; Chute DJ; Thorstad WL; Faraji F; Bishop JA; Mehrad M; Castro PD; Sikora AG; Thompson LDR; Chernock RD; Lang Kuhs KA; Wasman JK; Luo JR; Adelstein DJ; Koyfman SA; Lewis JS; Madabhushi A
    Cancer; 2022 Nov; 128(21):3831-3842. PubMed ID: 36066461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific aspects in patients with oropharyngeal squamous cell carcinoma: a bicentric cohort study.
    Klasen C; Wuerdemann N; Rothbart P; Prinz J; Eckel HNC; Suchan M; Kopp C; Johannsen J; Ziogas M; Charpentier A; Huebbers CU; Sharma SJ; Langer C; Arens C; Wagner S; Quaas A; Klußmann JP
    BMC Cancer; 2023 Nov; 23(1):1054. PubMed ID: 37919644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased overall survival in black patients with HPV-associated oropharyngeal cancer.
    Sheth S; Farquhar DR; Lenze NR; Mazul A; Brennan P; Anantharaman D; Abedi-Ardekani B; Zevallos JP; Hayes DN; Olshan F
    Am J Otolaryngol; 2021; 42(1):102780. PubMed ID: 33152576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
    Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
    Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis.
    Shenker RF; Razavian NB; D'Agostino RB; Mowery YM; Brizel DM; Hughes RT
    Oral Oncol; 2024 Jan; 148():106644. PubMed ID: 38006690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of human papillomavirus detection and the eighth edition of the TNM classification staging system in oropharyngeal squamous cell carcinoma: A single-center Polish study.
    Durzynska M; Kiprian D; Szumera-Cieckiewicz A; Leszczynski P; Florek A; Snietura M; Michalek IM; Bakula-Zalewska E; Prochorec-Sobieszek M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jun; 133(6):698-705. PubMed ID: 35165063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sociodemographic Factors Associated With Knowledge and Risk Perception of Human Papillomavirus and Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Among a Predominantly Black Population.
    Osazuwa-Peters N; Adjei Boakye E; Chen BY; Clancy J; Vallot PL; Su JL; Beck GE; Varvares MA
    JAMA Otolaryngol Head Neck Surg; 2017 Feb; 143(2):117-124. PubMed ID: 27711922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.